The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation

1. Karthikeyan, G.
2. Connolly, S.J.
3. Ntsekhe, M.
4. Benz, A.
5. Rangarajan, S.
6. Lewis, G.
7. Yun, Y.
8. Sharma, S.K.
9. Maklady, F.
10. Elghamrawy, A.E.
11. Kazmi, K.
12. Cabral, T.T.J.
13. Dayi, H.
14. Changsheng, M.
15. Gitura, B.M.
16. Avezum, A.
17. Zuhlke, L.
18. Lwabi, P.
19. Haileamlak, A.
20. Ogah, O.
21. Chillo, P.
22. Paniagua, M.
23. ElSayed, A.
24. Dans, A.
25. Gondwe-Chunda, L.
26. Molefe-Baikai, O.J.
27. Gonzalez-Hermosillo, J.A.
28. Hakim, J.
29. Damasceno, A.
30. Kamanzi, E.R.
31. Musuku, J.
32. Davletov, K.
33. Connolly, K.
34. Mayosi, B.M.
35. Yusuf, S.
36. Mostrar todos los/as autores/as +